Stockreport

Omeros Reports Narsoplimab TA-TMA Trial Success; Stock Surges [Yahoo! Finance]

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF trial results for its treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) using narsoplimab. The study showed a three-fold low [Read more]